Cencora Other Operating Income or Expenses 2010-2024 | COR
Cencora annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Cencora other operating income or expenses for the quarter ending September 30, 2024 were $-0.066B, a INF% decline year-over-year.
- Cencora other operating income or expenses for the twelve months ending September 30, 2024 were $-0.227B, a 688.52% decline year-over-year.
- Cencora annual other operating income or expenses for 2024 were $-0.227B, a INF% decline from 2023.
- Cencora annual other operating income or expenses for 2023 were $0B, a 100% decline from 2022.
- Cencora annual other operating income or expenses for 2022 were $-0.005B, a 56.32% decline from 2021.
| Cencora Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024 | $-227 |
| 2023 | $ |
| 2022 | $-5 |
| 2021 | $-11 |
| 2020 | $-362 |
| 2019 | $-570 |
| 2018 | $ |
| 2017 | $ |
| 2016 | $-140 |
| 2015 | $-913 |
| 2014 | $-423 |
| 2013 | $-90 |
| 2012 | $ |
| 2011 | $-7 |
| 2010 | $-3 |
| 2009 | $-12 |
| Cencora Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-66 |
| 2024-06-30 | $-14 |
| 2024-03-31 | $-226 |
| 2023-12-31 | $79 |
| 2023-09-30 | |
| 2023-06-30 | $67 |
| 2023-03-31 | $-16 |
| 2022-12-31 | $-13 |
| 2022-09-30 | $76 |
| 2022-06-30 | $-23 |
| 2022-03-31 | $-52 |
| 2021-12-31 | $-5 |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | $0 |
| 2020-06-30 | |
| 2020-03-31 | $-224 |
| 2019-12-31 | $-138 |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | $-570 |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | $-261 |
| 2016-06-30 | $84 |
| 2016-03-31 | $504 |
| 2015-12-31 | $-467 |
| 2015-09-30 | $196 |
| 2015-06-30 | $15 |
| 2015-03-31 | $-753 |
| 2014-12-31 | $-371 |
| 2014-09-30 | $-156 |
| 2014-06-30 | $-145 |
| 2014-03-31 | $-6 |
| 2013-12-31 | $-116 |
| 2013-09-30 | $-50 |
| 2013-06-30 | $-36 |
| 2013-03-31 | $-4 |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | $-8 |
| 2010-06-30 | $4 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $-6 |
| 2009-06-30 | $-0 |
| 2009-03-31 | $-4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $48.948B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.015B | 12.16 |
| DiDi Global (DIDIY) | China | $23.622B | 0.00 |
| ICON (ICLR) | Ireland | $17.731B | 15.79 |
| Natera (NTRA) | United States | $16.587B | 0.00 |
| Viatris (VTRS) | United States | $15.469B | 4.76 |
| Avantor (AVTR) | United States | $15.375B | 23.05 |
| Revvity (RVTY) | United States | $14.905B | 25.89 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.590B | 0.00 |
| Solventum (SOLV) | United States | $12.509B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.276B | 31.77 |
| Charles River Laboratories (CRL) | United States | $11.014B | 21.28 |
| Doximity (DOCS) | United States | $10.815B | 64.01 |
| HealthEquity (HQY) | United States | $8.629B | 46.83 |
| Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.043B | 32.79 |
| Life Times (LTH) | United States | $5.170B | 34.22 |
| Sotera Health (SHC) | United States | $4.557B | 24.38 |
| Organon (OGN) | United States | $4.131B | 4.17 |
| Surgery Partners (SGRY) | United States | $3.859B | 42.76 |
| BrightSpring Health Services (BTSG) | United States | $3.408B | 72.48 |
| PACS (PACS) | United States | $3.251B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.620B | 0.00 |
| Concentras Parent (CON) | United States | $2.500B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.337B | 0.00 |
| Premier (PINC) | United States | $2.292B | 11.44 |
| GeneDx Holdings (WGS) | United States | $2.137B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.589B | 0.00 |
| Progyny (PGNY) | United States | $1.499B | 26.37 |
| Pediatrix Medical (MD) | United States | $1.353B | 13.24 |
| Establishment Labs Holdings (ESTA) | $1.292B | 0.00 | |
| CareDx (CDNA) | United States | $1.268B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.104B | 7.49 |
| Embecta (EMBC) | United States | $0.897B | 5.98 |
| InnovAge Holding (INNV) | United States | $0.813B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.757B | 0.00 |
| SBC Medicals (SBC) | United States | $0.706B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| DocGo (DCGO) | United States | $0.409B | 15.38 |
| Enhabit (EHAB) | United States | $0.397B | 34.30 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.373B | 0.00 |
| LifeMD (LFMD) | United States | $0.252B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.225B | 0.00 |
| ModivCare (MODV) | United States | $0.221B | 12.05 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| Biodesix (BDSX) | United States | $0.199B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.63 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |